Announcements Trials
Browse Landscape

Phase

Phase 1 85Phase NA 39Phase 1/2 32Phase 2 21Phase 3 4Phase EARLY_PHASE1 2Phase 4 2Phase 2/3 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 22Breast 5Thoracic 4Head & Neck 3Gynecologic 2Sarcoma 1Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Ovarian Neoplasms 45Uterine Cervical Neoplasms 24Endometrial Neoplasms 24Fallopian Tube Neoplasms 18Breast Neoplasms 13Pancreatic Neoplasms 7Carcinoma, Ovarian Epithelial 7Uterine Cervical Dysplasia 6Sarcoma 6Lung Neoplasms 6Colorectal Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Prostatic Neoplasms 5Colonic Neoplasms 5Stomach Neoplasms 4Melanoma 4Head and Neck Neoplasms 4Brain Neoplasms 4Uterine Neoplasms 3Small Cell Lung Carcinoma 3Neoplasm Metastasis 3Liver Neoplasms 3Carcinoma, Renal Cell 3Vulvar Neoplasms 2Urinary Bladder Neoplasms 2Turcot syndrome 2Triple Negative Breast Neoplasms 2Recurrence 2Rectal Neoplasms 2Peritoneal Neoplasms 2

Interventions

Oncolytic Virotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Urinary Bladder Neoplasms × Gynecologic × Clear all
NCT05180851 2022-02-01

YSCH-01

Shanghai Fengxian District Central Hospital

Phase EARLY_PHASE1 Unknown
28 enrolled
BreastDermatologicGenitourinaryGynecologicHead & NeckThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Ovarian Neoplasms, Virus Diseases

NCT02646319 2019-06-06

Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations

Mayo Clinic

Phase EARLY_PHASE1 Completed
2 enrolled
BreastGenitourinaryGynecologic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Recurrence, Uterine Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡